Healthcare Industry News: brachytherapy
News Release - July 29, 2008
MEI Development Corporation and Varian Medical Systems Sign Sole-Source Supply Agreement for Radiation Therapy TechnologyPALO ALTO, Calif., July 29 (HSMN NewsFeed) -- Varian Medical Systems (NYSE: VAR ) today announced that it has entered into a strategic agreement with MEI Development Corporation and MEI Financial Services, LLC, both subsidiaries of the MEI Healthcare Group, LLC (MEI), for the purchase of radiation therapy systems for cancer treatment from Varian.
The agreement creates a strategic relationship in which Varian becomes the sole source of radiation therapy systems for MEI Development Corporation. Gordon Baltzer, President and CEO of The MEI Healthcare Group, LLC commented, "This strategic agreement ensures that our physician and hospital clients will have seamless access to Varian's cost effective and industry leading technology."
"We're pleased to have the opportunity to support MEI in its efforts to help its partner healthcare facilities enhance their cancer treatment capabilities," said Dow Wilson, President, Varian's Oncology Systems business. "MEI has been an excellent partner in our mutual battle against cancer, and we're looking forward to continuing our work together."
The MEI Healthcare Group, LLC, a privately held healthcare company, is headquartered in Coral Springs, Florida.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,800 people who are located at manufacturing sites in North America, China, and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/
Source: Varian Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsLong-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers
RaySearch Enters Into Interoperability Agreement With Varian
Varian Launches New Noona(R) Capabilities to Meet Growing Demand for Remote Cancer Patient Monitoring in Response to COVID-19's Impact on Healthcare